<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        47-15-93
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1993
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PLENDIL 10MG S.R.TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FELODIPINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        42.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AstraZeneca" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Plendil is used for the treatment of high blood pressure and vascular cramp in the heart (angina pectoris).</p><p><br />Plendil lowers the blood pressure by dilating the blood vessels. This results in the blood passing more easily through the vessels, and the blood pressure falls. Plendil affects neither the ability of the heart to contract, nor the pulse. High blood pressure often occurs as a result of the blood having difficulty in passing through the blood vessels.<br />&nbsp;</p><p>In cases of vascular cramps in the heart, the work of the heart is facilitated as a result of the blood vessels being widened.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Plendil:</strong><br /> if you are allergic to felodipine or any of the other ingredients of this medicine (listed in section 6)<br /> if you are pregnant<br /> if you have untreated heart failure<br /> if you have acute myocardial infarction (heart attack)<br /> if you have unstable angina pectoris<br /> if you have another serious heart disease (such as cardiac valvular obstruction, dynamic cardiac outflow obstruction).</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor before using Plendil if you have any of the following conditions:<br /> narrowing of the aortic valve in the heart (aortic stenosis)<br /> impaired liver function<br /> impaired kidney function<br /> heart failure<br /> low blood pressure</p><p><strong>Other medicines and Plendil</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription, herbal medicines or other herbal products.<br />Some medicines/herbal remedies can affect or be affected by treatment with Plendil. Examples are:</p><p> cimetidine (medicine to treat heartburn)<br /> erythromycin (medicine to treat infections)<br /> itraconazole (medicine to treat fungi)<br /> ketoconazole (medicine to treat fungi)<br /> medicines to treat HIV that are protease inhibitors (such as ritonavir)<br /> phenytoin (medicine used in epilepsy)<br /> carbamazepine (medicine used in epilepsy)<br /> rifampicin (medicine to treat infections)<br /> barbiturates (medicines to treat anxiety, sleeping problems and epilepsy)<br /> tacrolimus (medicine used in organ transplantations)<br /> Efavirenz or Nevirapine (used to treat HIV)<br /> Warfarin (used to thin the blood)<br /> Ciclosporin (mainly used by transplant patients but also used to treat rheumatoid arthritis and psoriasis)</p><p>In some cases, grapefruit juice may potentiate the effect of Plendil and should therefore be avoided.<br />Products containing St John&rsquo;s wort (Hypericum perforatum) (medicine to treat depression) may reduce the effect of Plendil and should therefore be avoided.</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><em>Pregnancy</em></p><p>Plendil should not be taken by pregnant women since there is a risk of harm to the foetus. Consult your doctor if you become or are planning to become pregnant.</p><p><em>Breast-feeding</em></p><p>Felodipine passes into breast milk. Breast-feeding should be discontinued during treatment with Plendil.</p><p><strong>Driving and using machines</strong><br />Plendil can slow down your reactions, and dizziness and fatigue can occur when you are taking the drug. You are responsible for judging whether you are fit to drive a motor vehicle or carry out work that requires heightened attention. One factor that may affect your ability in this respect is the use of medicines, because of their effects and/or side-effects. All these effects and side-effects are described in other sections. Therefore read all the information in this leaflet for guidance. Consult your doctor or pharmacist if you are uncertain.</p><p><strong>Plendil contains lactose</strong><br />If you have an intolerance to certain types of sugar, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><br /><em>Instructions for use</em><br />The tablets should preferably be taken in the morning on an empty stomach or together with a light low fat, low carbohydrate meal. The tablets must be swallowed whole with at least &frac12; glass of water. The tablets must not be divided, crushed or chewed.</p><p><em>Hypertension</em><br />Treatment should be started with 5 mg once a day. If necessary, your doctor may increase the dose or add another blood-pressure lowering medicine. The usual dose when treating this<em> disease for a long time is 5-10 mg once a day.</em></p><p><br /><em>Stable angina pectoris</em><br />Treatment should be started with 5 mg once a day and if needed, your doctor may increase the <em>dose to 10 mg once a day.</em></p><p><strong>If you take more Plendil than you should</strong><br />If you have taken too much of the medicine or if, for example, a child had taken the medicine by mistake, contact your doctor, the hospital or National Pharmacovigilance Center (NPC) for assessment of the risk and advice.</p><p><br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody experiences them.</p><p><br />Most of the side effects of Plendil are associated with the small arteries being dilated, and are signs that Plendil is having a blood pressure-lowering effect. They can occur at the beginning of treatment, during the first week, or in connection with an increase in dose, and they usually disappear by themselves.</p><p><em>Very common</em> (more than 1 person in 10 is affected): swollen ankles.<br /><em>Common </em>(fewer than 1 person in 10 is affected): headache, facial redness with a sensation of warmth.</p><p><em>Uncommon</em> (fewer than 1 person in 100 is affected): fatigue, dizziness, nausea, increased pulse rate, palpitations, low blood pressure, gastric pain, skin rash with or without itching, &lsquo;pins and needles&rsquo; sensation.</p><p><em>Rare</em> (fewer than 1 person in 1000 is affected): vomiting, nettle rash, impotence, fainting, joint pain, muscle pain.</p><p><em>Very rare</em> (fewer than 1 person in 10,000 is affected): hypersensitivity reactions such as fever or swelling of the lips and tongue, hypersensitivity to sunlight, inflammation of small blood vessels in the skin, altered liver values, increased need to urinate, inflammation of the gums (gingivitis), swelling of the gums (gingival hyperplasia). Good oral hygiene helps to avoid or alleviate swelling.<br />Isolated cases of confusion and sleep disturbances have been reported, but no definite connection with Plendil has been established.</p><p>Stop taking Plendil and contact your doctor immediately if you experience any of the following symptoms (angioedema):<br /> swelling of the face, tongue and/or throat<br /> difficulty swallowing<br /> nettle rash and breathing difficulties</p><p>If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not store above 30<sup>o</sup>C.<br />Do not use this medicine after the expiry date which is stated on the package after &ldquo;Exp.&rdquo;. The expiry date refers to the last day of that month.<br />Do not dispose of any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is felodipine 5 mg or 10 mg per prolonged-release tablet.<br />- The other ingredients (excipients) are propyl gallate, sodium stearyl fumarate, anhydrous lactose, carnauba wax, hypromellose, microcrystalline cellulose, hydroxypropyl cellulose, sodium aluminium silicate, macrogolglycerol hydroxystearate, macrogol, colourings (titanium dioxide E 171, iron oxide E 172).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Plendil 5 mg prolonged-release tablets: pink, round, biconvex, marked A/Fm on one side and 5 on the other, diameter 9 mm.
Plendil 10 mg prolonged-release tablets: reddish brown, round, marked A/FE on one side and 10 on the other, diameter 9 mm.

Pack size:
30 tablets (plastic bottle)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AstraZeneca AB<br />SE-151 85 S&ouml;dert&auml;lje<br />S&ouml;dert&auml;lje<br />Sweden</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2014
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>.(يستخدم عقار بلنديل لعلاج ضغط الدم المرتفع والمغص الصدري بالقلب(الذبحة الصدرية</p><p>يخفض بلنديل من ضغط الدم عبر توسيع الأوعية الدموية. وهذا يسبب تسهيل مرور الدم عبر الأوعية<br />وهو ما يخفّض ضغط الدم. لا يؤثر بلنديل على قدرة انقباض القلب ولا النبض. يحدث ارتفاع ضغط<br />الدم عادةً نتيجة لصعوبة مرور الدم عبر الأوعية الدموية.<br />في حالات المغص الصدري بالقلب، بتم تسهيل عمل القلب نتيجة اتساع الأوعية الدموية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم بلنديل</strong></p><ul><li>إذا كانت لديك حساسية تجاه فيلوديبين أو أي من المكونات الأخرى لهذا الدواء(المذكورة في<br />.(&nbsp;القسم 6</li><li>&nbsp;إذا كنتِ حاملاً</li><li>إذا عانيت من فشل قلب غير معالج</li><li>(إذا كنت تعاني من احتشاء عضلة القلب الحاد (نوبة قلبية</li><li>إذا كنت تعاني من ذبحة صدرية غير مستقرة</li><li>(إذا عانيت من مرض قلبي خطير آخر (مثل انسداد الصمام الشديد وانسداد التدفق القلبي</li></ul><p><strong>التحذيرات والتدابير الوقائية</strong></p><p>:تحدث إلى الطبيب قبل استخدام بلنديل إذا لاحظت أي مما يلي</p><ul><li>(ضيق الصمام الأبهري في القلب (تضيق الأبهر</li><li>قصور في وظيفة الكبد</li><li>قصور في وظائف الكلى</li><li>فشل القلب</li><li>انخفاض ضغط الدم.</li></ul><p><strong>الأدوية الأخرى وبلنديل</strong></p><p>أخبر الطبيب أو الصيدلي إذا كنت تعاني أو عانيت مؤخرًا أو قد تأخذ أي أدوية أخرى بما يشمل الأدوية<br />التي تتناولها دون وصفة طبية أو الأدوية العشبية أو المنتجات العشبية الأخرى.<br />:يمكن أن تؤثر الأدوية/العلاجات العشبية أو تتأثر بالعلاج ببلنديل. بعض الأمثلة</p><ul><li>(سيميتيدين (دواء يستخدم في معالجة الحرقة</li><li>(إريثرومايسين (دواء يستخدم في علاج حالات العدوى</li><li>(إيتراكونازول (دواء يستخدم في علاج الفطريات</li><li>(كيتوكونازول (دواء يستخدم في علاج الفطريات</li><li>(الأدوية التي تعالج الإيدز التي تعتبر مثبطات البروتياز (مثل ريتونافير</li><li>(الفينيتوين (دواء يستخدم في علاج الصرع</li><li>(الكربامازيين (دواء يستخدم في علاج الصرع</li><li>(ريفامبيسين (دواء يستخدم في علاج حالات العدوى</li><li>(باربيتورات (أدوية تستخدم في علاج القلق ومشكلات النوم والصرع</li><li>(تاكروليموس (دواء يستخدم في زراعة الأعضاء</li><li>(ايفافيرينز أو نيفيرابين (يستخدمان لعلاج فيروس نقص المناعة البشرية</li><li>(الوارفارين (يستخدم لترقيق الدم&nbsp;</li><li>السيكلوسبورين ( بالأساس يستخدم من قبل المرضى الخاضعين لزراعة الأعضاء ولكن يستخدم<br />(أيضا لعلاج مرض التهاب المفاصل والصدفية&nbsp;</li></ul><p>في بعض الحالات، قد يزيد عصير الجريب فروت من أثر بلنديل ومن ثم يجب تجنب تناوله.</p><p>المنتجات التي تحتوي على عشبه سانت جون (نبات هيوفاريقون)&nbsp;(دواء يستخدم في علاج الاكتئاب)&nbsp;قد<br />تقلل من تأثير بلنديل ومن ثم يجب تجنب تناولها.</p><p><strong>الحمل والرضاعة</strong></p><p>إذا كنتِ حاملاً&nbsp;أو ترضعين طبيعيًا، أو تعتقدين أنكِ حامل أو تخططين لإنجاب طفل، فاطلبي نصيحة<br />طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p><em>الحمل</em><br />يجب تجنب تناول بلنديل من المرأة الحامل نظرًا لخطورة إحداث ضرر على الجنين. استشيري الطبيب<br />إذا كنتِ حاملاً&nbsp;أو تعتزمين الحمل.</p><p><em>الرضاعة</em><br />فيلوديبين ينتقل عن طريق لبن الرضاعة. يجب الامتناع عن الرضاعة خلال فترة العلاج ببلنديل.</p><p><strong>القيادة واستخدام الآلات</strong><br />يمكن أن يقلل بلنديل من ردود الأفعال وقد تحدث بعض الدوخة والتعب عند تناول العقار. وأنت من<br />تحكم على حالتك من حيث إمكانية قيادة دراجة نارية أو سيارة أو تنفيذ أعمال تتطلب وعيًا زائدًا. أحد<br />العوامل التي تؤثر على قدرتك في هذا الصدد تتمثل في استخدام الدواء بسبب الآثار و/أو الآثار<br />الجانبية. تم ذكر كل هذه الآثار والآثار الجانبية في أقسام أخرى. ومن ثم قم بقراءة كل المعلومات<br />الواردة بهذه النشرة للتوجيه. استشر الطبيب أو الصيدلي إذا ساورتك الشكوك.</p><p><strong>يحتوي عقار بلنديل على اللاكتوز</strong><br />إذا كنت لا تحتمل أنواع محددة من السكريات فاتصل على الطبيب قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول دائمًا بلنديل بالطريقة التي يصفها لك طبيبك أو الصيدلي الخاص بك. ارجع لطبيبك أو الصيدلي<br />الخاص بك إذا لم تكن متأكّدًا.</p><p><em>إرشادات الاستخدام</em><br />يفضل تناول الأقراص في الصباح على معدة فارغة أو مع وجبة خفيفة تحتوي على قليل من الدهون<br />والكربوهيدرات. يجب ابتلاع الأقراص جملة واحدة مع نصف كوب مياه على الأقل. يجب تجنب كسر<br />الأقراص أو سحقها أو مضغها.</p><p><em>فرط ضغط الدم</em><br />يجب أن يبدأ العلاج بجرعة 5 ملجم مرة يوميًا. عند الضرورة، قد يزيد الطبيب<br />الجرعة أو يضيف دواء آخر لخفض ضغط الدم. الجرعة المعتادة عند علاج هذا</p><p>المرض لفترة طويلة هي 5-10 ملجم مرة يومياً</p><p><em>الذبحة الصدرية المستقرة</em><br />يجب بدء العلاج بجرعة 5 ملجم يوميًا وعند الضرورة قد يزيد الطبيب<br />الجرعة إلى 10 ملجم مرة يوميًا.</p><p><strong>إذا تناولت جرعة من بلنديل أكثر مما ينبغي</strong><br />إذا تناولت جرعة بلنديل أكثر مما ينبغي أو إذا أخد طفل على سبيل المثال الدواء عن طريق الخطأ<br />فاتصل على الطبيب أو المستشفى أو المركز الوطني للتيقظ والسلامة الدوائية لتقييم الخطر وطلب<br />النصيحة.</p><p>إذا كانت لديك أسئلة أخرى حول استخدام هذا الدواء، فتحدث إلى طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في جميع الأدوية ، يمكن أن يتسبّب هذا الدواء في حدوث آثار جانبية على الرغم من<br />أنها لا تصيب جميع المستخدمين.</p><p>ترتبط معظم الآثار الجانبية لعقار بلنديل بتوسعة الشرايين الصغيرة وهي تعتبر إشارات على أثر عقار<br />بلنديل على انخفاض ضغط الدم. وقد تحدث في بداية العلاج أو خلال الأسبوع الأول أو بالتوازي مع<br />زيادة الجرعة وهي تختفي من تلقاء نفسها.</p><p>شائعة جدًا (تؤثر على أكثر من شخص واحد من كل 01 أشخاص): تورم الكاحل.<br />شائعة (تؤثر على أقل من شخص واحد من كل 01 أشخاص): الصداع أو احمرار الوجه مع إحساس<br />بالحرارة.</p><p>غير شائعة(تؤثر على أقل من شخص واحد من كل 011 شخص): التعب أو الدوار أو زيادة معدل<br />ضربات القلب أو خفقان أو انخفاض ضغط الدم أو آلام في المعدة أو طفح جلدي مصاحب لحكة أو<br />&quot;غير مصاحب لها أو إحساس &quot;الوخز بالدبابيس والإبر</p><p>نادرة (تؤثر على أقل من شخص واحد من كل 0111 شخص): التقيؤ أو الحمى القراصية أو العجز<br />الجنسي أو الإغماء أو ألم المفاصل أو ألم العضلات.</p><p>نادرة جدًا (تؤثر على أقل من شخص واحد من كل 01111 شخص): تفاعلات فرط الحساسية مثل<br />الحمى أو تورم الشفاه واللسان أو فرط الحساسية في ضوء الشمس أو التهاب الأوعية الدموية<br />الصغيرة في الجلد أو تغير في صمامات الكبد أو حاجة زائدة إلى التبول أو التهاب اللثة (التهاب اللثة) أو<br />تورم اللثة (فرط التنسج اللثوي). تساعد العادات الصحية الفموية الجيدة في تجنب أو تخفيف التورم.</p><p>تم الإبلاغ عن حالات منفردة من الارتباك واضطراب النوم ولكن لا توجد صلة مباشرة قاطعة على صلة<br />ذلك ببلنديل.</p><p>توقف عن تناول بلنديل واتصل على الطبيب على الفور إذا واجهت أي من الأعراض التالية (الوذمة<br />:(الوعائية</p><ul><li>تورم الوجه و/أو اللسان و/أو الحلق.</li><li>صعوبة البلع.</li><li>حمى قراصية وصعوبة التنفس</li></ul><p>إذا شعرت بأي آثار جانبية، فتحدّث إلى طبيبك أو الصيدلي الخاص بك. وهذا يشمل أي آثار جانبية<br />محتملة غير مذكورة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احتفظ بهذا الدواء بعيدًا عن متناول الأطفال ورؤيتهم.</p><p>لا يُحفظ في درجة حرارة أعلى من 31 درجة مئوية.</p><p>لا تستخدم هذا العقار بعد تاريخ انتهاء صلاحيته المدون على العلبة الخارجية. يشير تاريخ انتهاء<br />الصلاحية إلى آخر يوم في الشهر المدوّن.</p><p>لا تتخلص من أي أدوية عبر مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي الخاص بك عن<br />إجراءات التخلص من الأدوية التي لم تعد تستعملها. حيث تساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- المادة النشطة هي فيلوديبين 5 ملجم أو 10ملجم في كل قرص ممتد المفعول.</p><p>- المكونات الأخرى (المكونات غير الأساسية) هي بروبيل غالات وفومارات ستيريل الصوديوم<br />واللاكتوز اللامائي وشمع كرنوبا وهايبروميلوز وسيلولوز بلوري مكروي وهيدروكسي بروبيل السليلوز<br />وسيليكات صوديوم ألومنيوم وماكروجوجليسيرول هيدروكسي ستيارات وماكروجل وألوان (ثاني<br />(أكسيد التيتانيوم E 171 وأكسيد الحديد الأحمر E 172</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أقراص بلنديل 5 ملجم ممتدة المفعول : أقراص زهرية دائرية محدبة الوجهين مكتوب على أحد جانبيها
A/Fm و 5 على الجانب الآخر بقطر 9 ملم.

أقراص بلنديل 10 ملجم ممتدة المفعول : أقراص حمراء تميل إلى البني محدبة الوجهين مكتوب
على أحد جانبيها A/FE و 10 على الجانب الآخر بقطر 9 ملم.
حجم العبوة:
31 قرصًا(عبوة بلاستيك)
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>AstraZeneca AB<br />SE-151 85 S&ouml;dert&auml;lje<br />S&ouml;dert&auml;lje<br />Sweden</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أبريل 2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Plendil 5 mg prolonged-release tablets 
Plendil 10 mg prolonged-release tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 prolonged-release tablet contains: felodipine 5 mg or 10 mg.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged-release tablets
Appearance
5 mg: pink, circular, biconvex, coded A/Fm on one side and 5 on the other, diameter 9 mm.
10 mg: red-brown, circular, coded A/FE on one side and 10 on the other, diameter 9 mm.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the management of Hypertension and prophylaxis of chronic stable angina pectoris.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The prolonged-release tablets should be taken once daily in the morning, and swallowed with water. The duration of effect is 24 hours. In order to maintain the prolonged-<br />release properties, the tablets must not be divided, chewed or crushed. The prolonged- release tablet may be taken on an empty stomach or together with a light meal that is low in fat and carbohydrates</p><p>&nbsp;</p><p><em>Hypertension</em><br />Adults (including elderly): The dose should be adjusted to the individual requirements of the patient. The recommended starting dose is 5 mg once daily. Depending on the patient`s response, the dose can, where applicable be decreased to 2.5 mg or increased to 10 mg daily. If necessary another antihypertensive agent may be added. The standard maintenance dose is 5 &ndash; 10 mg once daily. Doses higher than 20 mg daily are not usually needed. For dose titration purposes a 2.5 mg tablet is available. In elderly patients an initial treatment with 2.5 mg daily should be considered.</p><p>&nbsp;</p><p>Plendil can be used in combination with beta- blockers, ACE inhibitors or diuretics. The effects on blood pressure are likely to be additive and combination therapy will usually enhance the antihypertensive effect. Care should be taken to avoid hypotension.</p><p>&nbsp;</p><p><em>Stable angina pectoris</em><br />Adults: The dose should be adjusted individually. Treatment should be started with 5 mg once daily and if needed be increased to 10 mg once daily.</p><p>&nbsp;</p><p><em>Elderly</em><br />Initial treatment with 2.5mg daily dose should be considered.</p><p>&nbsp;</p><p><em>Impaired renal function</em><br />Impaired renal function does not affect plasma concentrations of felodipine. No dose adjustment is required. However, Plendil should be used with caution in patients with severely impaired renal function (see sections 5.2).</p><p>&nbsp;</p><p><em>Impaired hepatic function</em><br />Patients with impaired hepatic function may have elevated plasma concentrations of felodipine and may respond to treatment at lower doses (see section 4.4).</p><p>&nbsp;</p><p><em>Paediatric population</em><br />Due to limited clinical experience use of felodipine to paediatric patients with hypertension should be avoided, see sections 5.1 and 5.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Pregnancy
 Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
 Uncompensated heart failure
 Acute myocardial infarction
 Unstable angina pectoris
 Haemodynamically significant cardiac valvular obstruction
 Dynamic cardiac outflow obstruction
 Cardiogenic shock
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aortic stenosis, liver impairment, severely impaired renal function (GFR&lt;30 ml/min), heart failure after acute myocardial infarction.</p><p><br />Felodipine may like other vasodilators cause hypotension. This may lead to myocardial ischaemia in susceptible patients.</p><p><br />Felodipine must be used with caution in patients with a tendency to tachycardia.</p><p>Mild gingival enlargement has been reported in patients with pronounced gingivitis/periodontitis. The enlargement can be avoided or reversed by careful dental hygiene.</p><p><br />Felodipine is eliminated by the liver. Therefore, higher therapeutic concentrations and a higher treatment response may be expected in patients with clearly impaired hepatic function (see also section 4.2).</p><p>Plendil contains lactose. Patients with any of the following rare hereditary conditions should not use this medicine: galactose intolerance, total lactase deficiency or glucose- galactose malabsorption.</p><p><br />Concomitant administration of drugs that induce CYP 3A4 leads to greatly reduced levels of felodipine and the risk of a lack of effect (see section 4.5). This combination should be avoided.</p><p><br />Concomitant administration of drugs that are potent inhibitors of CYP 3A4 leads to markedly elevated levels of felodipine (see section 4.5). This combination should be avoided.</p><p><br />Concomitant intake of grapefruit juice leads to markedly elevated levels of felodipine (see section 4.5). This combination should be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Felodipine is metabolised in the liver by cytochrome P450 3A4 (CYP 3A4) substrate. Concomitant administration of substances that inhibit or induce CYP3A4 may affect plasma levels of felodipine.</p><p><em>CYP3A4 inducers</em><br />Drugs that increase the metabolism of felodipine by induction of P450 are, for example, carbamazepine, phenytoin, barbiturates e.g. phenobarbital, rifampicin, efavirenz, nevirapine, as well as St. John&rsquo;s wort (Hypericum perforatum). When administered together with carbamazepine, phenytoin and phenobarbital, the AUC of felodipine was reduced by 93% and Cmax by 82%. Combination with CYP 3A4 inducers should be avoided.</p><p><em>CYP3A4 inhibitors</em><br />Drugs that are potent CYP 3A4 inhibitors are, for example, azole antimycotics (itraconazole, ketoconazole) and macrolide antibiotics (erythromycin) and HIV protease inhibitors. Concomitant administration of itraconazole resulted in eight-fold increases of the Cmax of felodipine and six-fold increases of the AUC. Concomitant administration of erythromycin led to approximately 2.5-fold increases of the Cmax and the AUC of felodipine. Combination with potent CYP 3A4 inhibitors should be avoided.</p><p>Grapefruit juice inhibits CYP 3A4. Administration of felodipine together with grapefruit juice resulted in approximately two-fold increases of the Cmax and the AUC of felodipine. Combination with grapefruit juice should be avoided.</p><p><em>Cimetidine:</em> Concomitant treatment with cimetidine and felodipine increased the Cmax and AUC of felodipine by approx. 55%.</p><p><em>Other interactions</em><br />Tacrolimus: Felodipine may increase the concentration of tacrolimus. When used together, the concentration in serum of tacrolimus should be monitored and the dose may need to be adjusted.</p><p><em>Ciclosporin: </em>Concomitant treatment with ciclosporin and felodipine increased the Cmax of felodipine by 150% and the AUC by approx. 60%. The effect of felodipine on the kinetics of ciclosporin is, however, limited.</p><p><em>Other medicinal products with a high degree of protein binding: </em>The high degree of plasma protein binding of felodipine does not appear to affect the unbound fraction of other medicinal products with a high degree of protein binding such as warfarin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Fertility</em><br />Data on male and female fertility in patients are missing.</p><p><br /><em>Pregnancy</em><br />Pregnancy category C (please see section 5.3): Plendil should not be given during pregnancy.<br />There are no adequate data from the use of Plendil in pregnant women. Plendil is contraindicated during pregnancy, as teratogenic effects have been seen in animal studies (see section 5.3). Pregnancy must be excluded before treatment with Plendil is initiated. Calcium antagonists may inhibit premature contractions in the uterus, but there is no definite evidence of delayed delivery in a full-term pregnancy. There is a risk of hypoxia in the foetus in hypotensive mothers and of decreased perfusion of the uterus due to a redistribution of the blood flow through peripheral vasodilatation.</p><p><em>Lactation</em><br />Felodipine is excreted in the breast milk. If the nursing mother uses therapeutic doses of felodipine, only a very small dose is transferred via the breast milk to the child. There is insufficient experience of treatment with felodipine during lactation for an assessment<br />of the risks to the child. Plendil is therefore not recommended during lactation. In cases where the medical benefit of treatment is considered to be more important, lactation should therefore be discontinued as a safety measure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As dizziness and fatigue may occur in connection with Plendil treatment, this should be considered when high levels of attention are required, for example, when driving or operating machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Felodipine can cause flushing, headache, palpitations, dizziness and fatigue. Most of these reactions are dose-related and occur at the start of treatment or after a dose increase. If such reactions occur, they are usually short-lasting and abate with time.</p><p><br />Dose-related ankle swelling may occur in patients treated with felodipine. This is caused by precapillary vasodilatation and not related to any general fluid retention. Experience from clinical trials has shown that 2% of patients had to interrupt treatment due to ankle swelling.</p><p>Flushing, headache, palpitations, dizziness and fatigue may occur at the start of treatment or after a dose increase. These are normally transient.</p><p><br />Occasional cases of confusion and sleep disturbances have been reported, but a connection with felodipine has not been established with certainty.</p><p>Mild gingival enlargement has been reported after treatment with felodipine in patients with pronounced gingivitis/periodontitis. The enlargement can be avoided or reversed by careful dental hygiene.<br />Hyperglycaemia is a class-related undesirable effect, but has only been reported in individual cases for felodipine.</p><p>The following frequency definitions are used:<br />Very common &ge;1/10<br />Common &ge;1/100, &lt;1/10<br />Uncommon &ge;1/1,000, &lt;1/100<br />Rare &ge;1/10,000, &lt;1/1,000<br />Very rare &lt;1/10,000</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><strong>Organ system</strong></td><td><strong>Frequency</strong></td><td><strong>Undesirable effect</strong></td></tr><tr><td>Nervous system disorders</td><td><p>Common</p><p>Uncommon</p></td><td><p>Headache</p><p>Dizziness, paraesthesia</p></td></tr><tr><td>Cardiac disorders</td><td>Uncommon</td><td>Tachycardia, palpitations</td></tr><tr><td>Vascular disorders</td><td><p>Common</p><p>Uncommon</p><p>Rare</p></td><td><p>Flushing</p><p>Hypotension</p><p>Syncope</p></td></tr><tr><td>Gastrointestinal disorders</td><td><p>Uncommon</p><p>Rare</p><p>Very rare</p></td><td><p>Nausea, abdominal pain</p><p>Vomiting</p><p>Gingival hyperplasia, gingivitis</p></td></tr><tr><td>Hepatobiliary disorders</td><td>Very rare</td><td>Elevated liver enzymes</td></tr><tr><td>Skin and subcutaneous<br />tissue disorders</td><td><p>Uncommon</p><p>Rare</p><p>Very rare</p></td><td><p>Rash, pruritus</p><p>Urticaria</p><p>Photosensitivity reactions, leukocytoclastic vasculitis</p></td></tr><tr><td>Musculoskeletal and<br />connective tissue disorders</td><td>Rare</td><td>Arthralgia, myalgia</td></tr><tr><td>Renal and urinary disorders</td><td>Very rare</td><td>Pollakiuria</td></tr><tr><td>Reproductive system and<br />breast disorders</td><td>Rare</td><td>Impotence/sexual<br />dysfunction</td></tr><tr><td>General disorders and<br />administration site conditions</td><td><p>Very common</p><p>Uncommon</p><p>Very rare</p></td><td><p>Peripheral oedema</p><p>Fatigue</p><p>Hypersensitivity reactions, e.g. angioedema, fever</p></td></tr></tbody></table><p>&nbsp;</p><p>To report any side effect(s):<br /><strong> Saudi Arabia:</strong></p><p>The National Pharmacovigilance and Drug Saftey Centre (NPC)</p><p>o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p><strong> Other GCC states:</strong></p><p>- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Toxicity: </em>10 mg to a two-year-old child caused mild intoxication. 150-200 mg to a 17- year-old and 250 mg to an adult caused mild to moderate intoxication. Felodipine probably has a more pronounced effect on the peripheral circulation than on the heart compared with other drugs in the same group.</p><p><br /><em>Symptoms:</em> The symptoms of intoxication with prolonged-release tablets may be delayed 12-16 hours and severe symptoms may set in after several days. Overdose may&nbsp;cause considerable peripheral vasodilation with marked hypotension and sometimes bradycardia. AV block I-III, AV dissociation, VES, ventricular fibrillation, asystole. Dizziness, headache, impaired consciousness, coma, spasms. Dyspnoea, pulmonary oedema (non-cardiac) and apnoea. Possibly ARDS (Adult Respiratory Distress Syndrome). Acidosis, hypokalaemia, hyperglycaemia, potentially hypocalcaemia. Flushing, hypothermia. Nausea and vomiting.</p><p><em>Management:</em> Activated charcoal, gastric lavage if required, in certain cases also late after exposure (prolonged-release tablets can aggregate).</p><p>Atropine (0.25-0.5 mg intravenously to adults, 10-20 mcg/kg to children) should be given before gastric lavage (due to the risk of vagal stimulation). Intake of a large dose of prolonged-release preparations can give cause for intestinal lavage (please contact Swedish Poisons Information Centre for discussion).</p><p>ECG monitoring. Ventilator treatment on broad indication. Correction of acid-base and electrolyte status.</p><p>If severe hypotension occurs, symptomatic treatment should be initiated.<br />The patient should be placed in a supine position with the legs elevated. In the event of accompanying bradycardia, 0.5-1 mg atropine should be administered intravenously. If this is not sufficient, plasma volume should be increased by infusion of e.g. glucose, saline or dextran. Sympathomimetics with predominant effect on the &alpha;1-adrenoceptor may be given if the aforementioned measures are not sufficient.</p><p>In circulatory arrest related to overdose, resuscitation attempts may be required for several hours. In the case of spasms, diazepam should be given. Otherwise symptomatic therapy.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group:<br />Calcium antagonist, ATC code: C08C A02<br />Felodipine (Plendil) is a vasoselective calcium antagonist for the treatment of hypertension and stable angina pectoris.<br />The active substance in Plendil, felodipine, is a dihydropyridine derivate. Felodipine is a racemate.<br />Felodipine exerts its effect by reducing peripheral vascular resistance, particularly in arterial resistance vessels. The electrical and contractile activity of vascular smooth muscle cells is inhibited via an effect on the calcium channels in the cell membranes&nbsp;Due to the selective effect on smooth muscle in arterial resistance vessels, felodipine in therapeutic doses has no negative inotropic effects on the heart, nor any clinically significant electrophysiological cardiac effects.<br />Felodipine relaxes smooth muscle in the airways. Clinical experience has shown that felodipine has little effect on gastrointestinal motor function. No clinically significant effect of felodipine on blood lipids has been observed during long-term treatment, nor have any clinically significant effects on metabolic control (HbA1c) been observed in patients with type II diabetes during six months of treatment.<br />Felodipine can generally also be given to patients with concomitant impairment of left ventricular function who receive conventional therapy, or with asthma, diabetes, gout or hyperlipidaemia.</p><p><em>Anti-hypertensive effect:</em> Felodipine lowers arterial blood pressure by decreasing peripheral vascular resistance. Treatment of hypertensive patients with Plendil reduces the blood pressure in the lying down, sitting and standing positions, and at rest and during exercise. Felodipine does not give rise to orthostatic hypotension, as the substance has no effect on venous smooth muscle or adrenergic control mechanisms.</p><p>The lowered blood pressure may initially cause a temporary reflex increase in heart rate and cardiac output. The increased heart rate is counteracted when felodipine is given together with beta-blockers. Plasma concentrations of felodipine are positively correlated to the decrease in total peripheral resistance and blood pressure. At steady state the effect remains over the entire dose range and gives a 24-hour reduction in blood pressure.<br />Treatment with felodipine is associated with regression of left ventricular hypertrophy. Felodipine has a natriuretic and diuretic effect but no potassiuretic effect. The tubular reabsorption of sodium and water is reduced, which may explain the absence of salt and fluid retention in the patient. Felodipine reduces renal vascular resistance and increases renal perfusion. The glomerular filtration rate is unchanged. Felodipine does not influence albumin excretion.</p><p>In the so-called HOT (Hypertension Optimal Treatment) study, including 18,790 patients with mild to moderate hypertension, treatment with Plendil, in combination with ACE inhibitors, beta-blockers and/or diuretics, if needed, resulted in a diastolic blood pressure (DBP) of &le; 90 mmHg in 93% of patients.<br />In the same study, the incidence of cardiovascular events in patients with type II<br />diabetes (n=1501) was significantly lower (50%) in the group where the target DBP was<br />&le; 80 mmHg (11.9/1000 patient years), compared with the group where the target DBP<br />was below 90 mmHg (24.4/1000 patient years).</p><p>Plendil was included as one of two calcium antagonists in the Swedish STOP-2 study, performed in 6,614 hypertensive patients aged 70-84 years. The study indicates that hypertensive treatment initiated with dihydropyridine calcium antagonists and with the addition of beta-blockers, if needed, has no negative effect on cardiovascular mortality compared with conventional treatment with beta-blockers and/or diuretics.</p><p>For the treatment of hypertensive patients, Plendil can be used as monotherapy or in combination with other antihypertensive drugs, such as beta-blockers, diuretics or ACE inhibitors.</p><p><em>Anti-anginal effect:</em> Felodipine exerts its effect through dilatation of coronary vessels, which also improves perfusion and the oxygen supply to the heart. Cardiac work load is decreased through a reduction of the peripheral arterial resistance (reduced afterload), which results in reduced oxygen demand in the myocardium. Coronary vasospasm is counteracted by felodipine.</p><p>Felodipine improves exercise capacity and reduces the number of anginal attacks in patients with stable effort-induced angina.<br />Initially during treatment there is a transient reflex increase in heart rate, which is counteracted if Plendil is given in combination with beta-blockers. The time to onset of effect is two hours and the effect duration is 24 hours.<br />Plendil can be used in combination with beta-blockers or as monotherapy for the treatment of patients with angina pectoris.</p><p><em>Paediatric population</em><br />There is limited clinical experience of the use of felodipine in hypertensive paediatric patients. In a randomised, double-blind, parallel group study, the antihypertensive effect of once daily felodipine in children aged 6-16 years with primary hypertension was studied. They were treated for three weeks with 2.5 mg (n=33), 5 mg (n=33), 10 mg (n=31) or placebo (n=35). The study failed to demonstrate any antihypertensive effect in children aged 6-16 years.</p><p>The long-term effects of felodipine on growth, puberty and general development have not been studied. The long-term efficacy of antihypertensive therapy as therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood has also not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The active substance in Plendil prolonged-release tablets, felodipine, is imbedded in a polymer that forms a gel layer in contact with water, from which felodipine is released continuously, which leads to a slow onset of effect.<br />The bioavailability of felodipine is approximately 15% and is independent of concomitant food intake. However, the rate of absorption &ndash; although not the degree of absorption &ndash; is affected by concomitant intake of food, and the maximum plasma concentration is thereby increased by approx. 65%. The maximum plasma concentration is reached after 3-5 hours. The degree of binding to plasma proteins is approximately<br />99%. The volume of distribution at steady state is 10 L/kg. The half-life of felodipine in the elimination phase is approximately 25 hours and steady state is reached after 5 days. There is no risk of accumulation during long-term treatment.</p><p>Average clearance is 1200 ml/min. Reduced clearance in elderly patients and patients with impaired liver function leads to higher plasma concentrations of felodipine. However, age can only partly explain the interindividual variations in plasma concentrations. Felodipine is metabolised in the liver by cytochrome P450 3A4 and none of the identified metabolites has a vasodilating effect. About 70% of a given dose is excreted as metabolites in the urine and the rest is excreted in the faeces. Less than<br />0.5% of a given dose is excreted unchanged in the urine.<br />Impaired renal function does not affect plasma concentrations of felodipine, although there is accumulation of inactive metabolites. Felodipine is not eliminated by haemodialysis.</p><p><em>Paediatric population</em><br />In a single-dose (felodipine prolonged-release tablet 5 mg) pharmacokinetic study with<br />a limited number of children aged between 6 and 16 years (n=12) there was no apparent relationship between the age and AUC, Cmax or half-life of felodipine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Conventional studies regarding general toxicity, genotoxicity and carcinogenicity did not show any particular risks for humans. In animal studies calcium antagonists have given rise to embryotoxic and/or teratogenic effects in several species, mainly in the form of distal skeletal malformations. In reproduction toxicology studies with felodipine, prolonged pregnancies and difficult labour were observed in the rat, and impaired development of distal phalanges was seen in the rabbit (probably caused by decreased uteroplacental perfusion). These observations do not indicate any direct teratogenic effects but rather secondary consequences of the pharmacodynamic effects of felodipine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxypropyl cellulose, hydroxypropyl methylcellulose, lactose anhydrous, microcrystalline cellulose, macrogolglycerol hydroxystearate, propyl gallate, sodium aluminium silicate, sodium stearyl fumarate, carnauba wax, iron oxide (E 172), macrogol, titanium dioxide (E 171).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged-release tablets 5 mg, blister pack and plastic bottle
Prolonged-release tablets 10 mg, blister pack and plastic bottle
2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><strong>Prolonged-release tablets 5 mg,</strong></em> blister pack and plastic bottle</p><p><em><strong>Prolonged-release tablets 10 mg, </strong></em>blister pack and plastic bottle</p><p>No special storage instructions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Prolonged-release tablets 5 mg</strong><br />Plastic bottle<br />30 tablets (bottle)</p><p><br /><strong>Prolonged-release tablets 10 mg</strong><br />Plastic bottle<br />30 tablets (bottle)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
P.O. Box 5132, Riyadh 11422, Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                01.04.2014
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>